Novo Nordisk presents positive phase 3b trial results in switching to investigational Mim8 (denecimig) prophylaxis from emicizumab in haemophilia A

Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers

FDA approves Dupixent as first targeted therapy for rare skin disease bullous pemphigoid

Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement

Dizal completes enrolment in sunvozertinib vs. platinum doublet phase III study

Oxurion signs LOI to acquire majority stake in preclinical microbiology CRO

Ritedose unveils new distribution and logistics facility

Simcere Zaiming reports first patient dosed in SIM0500 US Phase 1 trial in patients with relapsed/refractory multiple myeloma

IMUNON unveils promising Phase 2 translational data for IMNN-001 in advanced ovarian cancer

FDA approval of Keytruda sets positive regulatory precedent for CEL-SCI's Multikine in PD-L1 negative head and neck cancer

Oncoinvent reports positive Phase 1/2a data for Radspherin in colorectal cancer patients with peritoneal metastases

TME Pharma and SERI partner to advance NOX-E36 in ophthalmology through option framework agreement

Incanthera reports breakthrough UV protection findings for Skin + CELL

Camurus study shows treatment effects with CAM2029 in polycystic liver disease patients

Clarity Pharmaceuticals agrees commercial manufacturing deal for Cu-64 SAR-bisPSMA with SpectronRx